ESR1 amplification is rare in breast cancer and is associated with high grade and high proliferation: A multiplex ligation-dependent probe amplification study

Analytical Cellular Pathology

Volumn 33, Issue 1, 2010, Pages 13-18

  Moelans, Cathy B ^a   Monsuur, Hanneke N ^a   De Pinth, Johannes H ^a   Radersma, Remco D ^a   De Weger, Roel A ^a   Van Diest, Paul J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

amplification; breast cancer; ESR1; MLPA

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR ALPHA; ESR1 PROTEIN, HUMAN;

ADULT; ARTICLE; BREAST CANCER; CANCER SIZE; CELL PROLIFERATION; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DOSAGE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; BREAST TUMOR; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; NUCLEIC ACID AMPLIFICATION; PATHOLOGY; POLYMERASE CHAIN REACTION;

BREAST NEOPLASMS; CELL PROLIFERATION; ESTROGEN RECEPTOR ALPHA; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; MIDDLE AGED; NUCLEIC ACID AMPLIFICATION TECHNIQUES; POLYMERASE CHAIN REACTION;

EID: 79952279120     PISSN: 22107177     EISSN: 22107185     Source Type: Journal    
DOI: 10.3233/ACP-CLO-2010-0527     Document Type: Article

References (24)

1. D.G. Albertson, Conflicting evidence on the frequency of ESR1 amplification in breast cancer, Nat. Genet. 40 (2008), 821-822. (Pubitemid 351913669)
2. D.C. Allred and S.K. Mohsin, Biological features of premalignant disease in the human breast, J. Mammary Gland Biol. Neoplasia 5 (2000), 351-364. (Pubitemid 32236767)
3. L.A. Brown, J. Hoog, S.F. Chin, Y. Tao, A.A. Zayed, K. Chin et al., ESR1 gene amplification in breast cancer: a common phenomenon?, Nat. Genet. 40 (2008), 806-807. (Pubitemid 351913659)
4. D.J. Bunyan, D.M. Eccles, J. Sillibourne, E. Wilkins, N.S. Thomas, J. Shea-Simonds et al., Dosage analysis of cancer predisposition genes by multiplex ligation-dependent probe amplification, Br. J. Cancer 91 (2004), 1155-1159. (Pubitemid 39336256)
5. J. Coffa, M.A. van de Wiel, B. Diosdado, B. Carvalho, J. Schouten and G.A. Meijer, MLPAnalyzer: data analysis tool for reliable automated normalization of MLPA fragment data, Cell. Oncol. 30 (2008), 323-335. (Pubitemid 352032908)
6. B. Ejlertsen, K.V. Nielsen, B.B. Rasmussen, E. Balslev, S. Muller and H.T. Mouridsen, Amplification of ESR1 may predict resistance to adjuvant tamoxifen in postmenopausal patients with hormone receptor positive breast cancer, Breast Cancer Res. Treat. 106 (2007), S34-Abstract 402.
7. S.I. Hayashi, H. Eguchi, K. Tanimoto, T. Yoshida, Y. Omoto, A. Inoue et al., The expression and function of estrogen receptor alpha and beta in human breast cancer and its clinical application, Endocr. Relat. Cancer 10 (2003), 193-202. (Pubitemid 36763534)
8. F. Holst, P. Stahl, O. Hellwinkel, A.-M. Dancau, A. Krohn, L. Wuth et al., Reply to: ESR1 gene amplification in breast cancer: a common phenomenon?, Nature 40 (2008), 810-812. (Pubitemid 351913663)
9. F. Holst, P.R. Stahl, C. Ruiz, O. Hellwinkel, Z. Jehan, M. Wendland et al., Estrogen receptor alpha (ESR1) gene amplification is frequent in breast cancer, Nat. Genet. 39 (2007), 655-660. (Pubitemid 46676104)
10. H.M. Horlings, A. Bergamaschi, S.H. Nordgard, Y.H. Kim, W. Han, D.Y. Noh et al., ESR1 gene amplification in breast cancer: a common phenomenon?, Nat. Genet. 40 (2008), 807-808. (Pubitemid 351913660)
11. A. Howell and A. Buzdar, Are aromatase inhibitors superior to antiestrogens?, J. Steroid Biochem. Mol. Biol. 93 (2005), 237-247. (Pubitemid 40602496)
12. M.B. Lyng, K. Vang, A. Knoop, H. Ditzel, A.E. Lykkesfeldt, S. Muller et al., ER status measured by FISH is a better predictor of prognosis in ER positive, postmenopausal breast cancer patients treated with adjuvant tamoxifen than ER status measured by RT-qPCR or IHC, in: San Antonio Breast Cancer Symposium, San Antonio, TX, USA, 2009, Poster # 2004.
13. C.X. Ma, C.G. Sanchez and M.J. Ellis, Predicting endocrine therapy responsiveness in breast cancer, Oncology 23 (2009), 133-142.
14. L.P. Menasce, G.R. White, C.J. Harrison and J.M. Boyle, Localization of the estrogen receptor locus (ESR) to chromosome 6q25.1 by FISH and a simple post-FISH banding technique, Genomics 17 (1993), 263-265. (Pubitemid 23205095)
15. C.B. Moelans, R.A. de Weger, M.T. van Blokland, C. Ezendam, S. Elshof, M.G. Tilanus et al., HER-2/neu amplification testing in breast cancer by multiplex ligation-dependent probe amplification in comparison with immunohistochemistry and in situ hybridization, Cell. Oncol. 31 (2009), 1-10.
16. C.B. Moelans, R.A. de Weger, M.T. van Blokland, W.E. van der and P.J. van Diest, Simultaneous detection of TOP2A and HER2 gene amplification by multiplex ligation-dependent probe amplification in breast cancer, Mod. Pathol. 23 (2010), 62-70.
17. C.B. Moelans, R.A. de Weger, C. Ezendam and P.J. van Diest, HER-2/neu amplification testing in breast cancer by Multiplex Ligation-dependent Probe Amplification: influence of manualand laser microdissection, BMC Cancer 9 (2009), 4.
18. C.B. Moelans, R.A. de Weger and P.J. van Diest, Absence of chromosome 17 polysomy in breast cancer: analysis by CEP17 chromogenic in situ hybridization and multiplex ligationdependent probe amplification, Breast Cancer Res. Treat. 120 (2010), 1-7.
19. J.S. Reis-Filho, S. Drury, M.B. Lambros, C. Marchio, N. Johnson, R. Natrajan et al., ESR1 gene amplification in breast cancer: a common phenomenon?, Nat. Genet. 40 (2008), 809-810. (Pubitemid 351913662)
20. S. Tomita, Z. Zhang, M. Nakano, M. Ibusuki, T. Kawazoe, Y. Yamamoto et al., Estrogen receptor alpha gene ESR1 amplificationmay predict endocrine therapy responsiveness in breast cancer patients, Cancer Sci. 100 (2009), 1012-1017.
21. P.J. van Diest, No consent should be needed for using leftover body material for scientific purposes, BMJ 325 (2002), 648-651.
22. P.J. van Diest, J.P. Baak, P. Matze-Cok, E.C. Wisse-Brekelmans, C.M. van Galen, P.H. Kurver et al., Reproducibility of mitosis counting in 2,469 breast cancer specimens: results from the Multicenter Morphometric Mammary Carcinoma Project, Hum. Pathol. 23 (1992), 603-607.
23. A. Vincent-Salomon, V. Raynal, C. Lucchesi, N. Gruel and O. Delattre, ESR1 gene amplification in breast cancer: a common phenomenon?, Nat. Genet. 40 (2008), 809. (Pubitemid 351913661)
24. A.E.Wakeling, Similarities and distinctions in the mode of action of different classes of antioestrogens, Endocr. Relat. Cancer 7 (2000), 17-28. (Pubitemid 30305868)